Sanofi Current Tax Expense Income
Sanofi (SNY) reported Current Tax Expense Income of EUR 3.44 billion for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-17.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:CurrentTaxExpenseIncome · last filed 2026-02-17
| Period end | Current Tax Expense Income 6 month | Current Tax Expense Income 6 month as first filed | Current Tax Expense Income 12 month | Current Tax Expense Income 12 month as first filed |
|---|---|---|---|---|
| 2025-12-31 | 3.44B EUR 20-F · filed 2026-02-17 | |||
| 2025-06-30 | 1.20B EUR 6-K · filed 2025-10-27 | |||
| 2024-12-31 | 2.15B EUR 20-F · filed 2026-02-17 | |||
| 2024-06-30 | 1.11B EUR 6-K · filed 2025-10-27 | 1.24B EUR 6-K · filed 2024-07-25 | ||
| 2023-12-31 | 2.25B EUR 20-F · filed 2026-02-17 | 2.56B EUR 20-F · filed 2024-02-23 | ||
| 2023-06-30 | 1.17B EUR 6-K · filed 2024-07-25 | |||
| 2022-12-31 | 2.63B EUR 20-F · filed 2025-02-13 | 2.77B EUR 20-F · filed 2023-02-24 | ||
| 2022-06-30 | 1.09B EUR 6-K · filed 2023-07-28 | |||
| 2021-12-31 | 1.91B EUR 20-F · filed 2024-02-23 | |||
| 2021-06-30 | 806.00M EUR 6-K · filed 2022-07-28 | |||
| 2020-12-31 | 1.91B EUR 20-F · filed 2023-02-24 | 1.91B EUR 20-F · filed 2021-03-04 | ||
| 2020-06-30 | 1.13B EUR 6-K · filed 2021-07-29 | |||
| 2019-12-31 | 1.89B EUR 20-F · filed 2022-02-23 | |||
| 2019-06-30 | 828.00M EUR 6-K · filed 2020-07-29 | |||
| 2018-12-31 | 1.21B EUR 20-F · filed 2021-03-04 | |||
| 2017-12-31 | 2.63B EUR 20-F · filed 2020-03-05 | |||
| 2016-12-31 | 1.87B EUR 20-F · filed 2019-03-08 | |||
| 2015-12-31 | 1.98B EUR 20-F/A · filed 2018-03-16 |